Biobanking Market to track and analyze competitive developments such as agreements, collaborations, and partnerships; acquisitions; and product launches in the biobanking market
The biobanking market is expected to reach USD 2.69 billion by 2022 from USD 1.85 billion in 2017, at a CAGR of 7.8%.
Get Sample Copy for more professional insights Here@ www.reportsnreports.com/contacts/r…aspx?name=1148472
Factors driving the growth of this market include the increasing number of genomics research activities for studying diseases; advances in biobanking and the growing trend of conserving cord blood stem cells of newborns; government & private funding to support regenerative medicine research, and the growing need for cost-effective drug discovery and development. On the other hand, the growth of this market is hindered to some extent due to the high cost of automation and issues related to bio specimen sample procurement.
“Automated storage is expected to register the highest CAGR during the forecast period”
The biobanking market is classified by storage type into manual and automated storage.
The automated storage type segment is expected to grow at a higher rate during the forecast period. This is attributed to launch of new and advanced automated storage equipment and increasing demand for the quality storage of samples.
“Regenerative medicine to dominate the market during the forecast period”
The biobanking market is segmented based on applications regenerative medicine, life science research, and clinical research. In 2017, the regenerative medicine segment is expected to command the largest share and is also estimated to grow at the fastest rate as compared to other segments.
This can be attributed to increasing research activities in the field of regenerative medicine and rising demand for well-annotated and quality bio samples for research.
Access Biobanking Market 2017-2022 spreads across 171 pages profiling 13 companies and supported with 123 tables and 38 figures available at www.reportsnreports.com/contacts/d…spx?name=1148472
The key players in the biobanking market include Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)], Chart Industries (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Micronic (Netherlands), LVL Technologies GmbH & Co. KG (Germany), Panasonic Healthcare Holdings Co. Ltd (Japan), Greiner Bio One [Greiner Holding AG, Austria)], Biokryo GmbH (Germany), Biobank AS (Norway), Biorep Technologies Inc. (U.S.), Cell & Co Bioservices (France), RUCDR infinite biologics (U.S.), Modul-Bio (France), CSols Ltd (U.K.), Ziath (U.K.), and LabVantage Solutions Inc. (U.S.).
Target Audience for this Report:
- Biobanking associations
- Research & consulting firms
- Distributors of biobanking research products
- Contract manufacturers of biobanking equipment and consumables
- Research institutes and clinical research organizations (CROs)
- Venture capitalists
- Government associations
Key point from table of content
6 Global Biobanking Market, By Product and Service
6.2.1 Storage Equipment
6.2.2 Sample Analysis Equipment
7 Global Biobanking Market, By Sample Type
7.2 Blood Products
7.3 Human Tissues
7.4 Cell Lines
8 Global Biobanking Market, By Storage Type
8.2 Manual Storage
8.3 Automated Storage
9 Global Biobanking Market, By Application
9.2 Regenerative Medicine
9.3 Life Science Research
9.4 Clinical Research
Browse Here for full Report with TOC: www.reportsnreports.com/reports/11…a-st-to-2022.html
For more information:Make an Inquiry about this report HERE!